A phase II trial of gemcitabine and S-1 therapy in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP-03).
Akio Saiura
No relevant relationships to disclose
Hideki Ueno
Honoraria - Lilly; Taiho Pharmaceutical
Tomoo Kosuge
No relevant relationships to disclose
Yutaka Matsuyama
No relevant relationships to disclose
Hiroshi Ishii
No relevant relationships to disclose
Akimasa Nakao
No relevant relationships to disclose
Ryuichiro Doi
No relevant relationships to disclose
Masao Tanaka
Consultant or Advisory Role - Taiho Pharmaceutical
Honoraria - Taiho Pharmaceutical